1-9 of 9
Artur Jurczyszyn, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Breaking the Glass Ceiling of Age in Transplant in Multiple Myeloma

Free
Pashna N. Munshi, MD, Parameswaran Hari, MBBS, MD, David H. Vesole, MD PhD, Artur Jurczyszyn, MD, Jan Zaucha, MD PhD, Omar Davila, Shaji K. Kumar, MD, Nina D. Shah, MD, Muzaffar H. Qazilbash, MD, Anita D'Souza, MDMS
Journal: Blood
Blood (2019) 134 (Supplement_1): 782.
https://doi.org/10.1182/blood-2019-124804
Published: 2019
Journal Articles

Efficacy of Isatuximab with Pomalidomide and Dexamethasone in Elderly Patients with Relapsed/Refractory Multiple Myeloma: Icaria-MM Subgroup Analysis

Free
Fredrik H. Schjesvold, MD PhD, Paul G. Richardson, MD, Michel Attal, MD PhD, Thierry Facon, MD, Adrián Alegre, MD, Andrew Spencer, DM, Artur Jurczyszyn, MD, Kazutaka Sunami, MD PhD, Laurent Frenzel, MD PhD, Chang-Ki Min, MD PhD, Solenn Le-Guennec, Frank Campana, MD, Helgi van de Velde, MD PhD, Samira Bensfia, MD, Sara Bringhen
Journal: Blood
Blood (2019) 134 (Supplement_1): 1893.
https://doi.org/10.1182/blood-2019-128010
Published: 2019
Journal Articles

The MP0250-CP201 Mirror Study: A Phase 2 Study Update of MP0250 Plus Bortezomib and Dexamethasone in Relapse/Refractory Multiple Myeloma (RRMM) Patients Previously Exposed to Proteasome Inhibitors and Immunomodulatory Drugs

Free
Norbert Grząśko, MD PhD, Stefan Knop, Hartmut Goldschmidt, MD, Marc S Raab, MD PhD, Jan Dürig, Sara Bringhen, Mattia D'Agostino, MD, Barbara Gamberi, Elena Rivolti, MD, Angelo Vacca, MD PhD, Roberto Ria, MD, Artur Jurczyszyn, MD, Jorge Castellano Acosta, MD, Doris Lang, Guy Lemaillet, PhD, Bansod Sudhir, MD, Monika Szarejko, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1899.
https://doi.org/10.1182/blood-2019-129827
Published: 2019
Journal Articles

The Prognostic Impact of t(14;16) in Multiple Myeloma: A Multicenter Retrospective Study of 213 Patients. Is It Time to Revise the Revised ISS?

Free
Artur Jurczyszyn, MD, Sarah Goldman-Mazur, MD, Jorge J. Castillo, MD, Anna Waszczuk-Gajda, Norbert Grząśko, MD PhD, Jakub Radocha, MD, Max Bittrich, MD, Alessandro Gozzetti, MD PhD, Lidia Usnarska-Zubkiewicz, Iwona Hus, Andrew J Yee, MD, David S Jayabalan, BSMS, MSc, Ruben Niesvizky, MD, Julia Kelman, Daniel Coriu, MD, Laura Rosinol Dachs, Łukasz Szukalski, Julio Dávila, Veronica Gonzalez De La Calle, MD PhD, Krzysztof Jamroziak, Irit Avivi, MD, Yael C Cohen, Anna Suska, MD, Aimee Chappell, Deepu Madduri, Saurabh Chhabra, MD, Ariel Kleman, MD, Parameswaran Hari, MBBS, MD, Paweł Robak, Massimo Gentile, Izabela Kozłowska, Stuart L. Goldberg, MD, David H Vesole
Journal: Blood
Blood (2018) 132 (Supplement 1): 4452.
https://doi.org/10.1182/blood-2018-99-115971
Published: 2018
Journal Articles

Hematogenous Extramedullary Relapse in Multiple Myeloma - A Multicenter Retrospective Study in 127 Patients

Free
Irit Avivi, MD, Yael C Cohen, Gabor Mikala, MD PhD, Laurent Garderet, Mor Seny Gueye, David S Jayabalan, BSMS,MSc, Sophia Glickman, Ruben Niesvizky, MD, Alessandro Gozzetti, MD PhD, Katarzyna Wiśniewska-Piąty, Anna Waszczuk-Gajda, Lidia Usnarska-Zubkiewicz, Iwona Hus, Renata Guzicka Kazmierczak, Jakub Radocha, MD, Vibor Milunovic, Julio Dávila, Massimo Gentile, Anna Suska, Sarah Goldman-Mazur, MD, Jorge J. Castillo, MD, Artur Jurczyszyn, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2004.
https://doi.org/10.1182/blood-2018-99-112750
Published: 2018
Journal Articles

MP0250 Combined with Bortezomib and Dexamethasone in Multiple Myeloma Patients Previoulsy Exposed to Proteasome Inhibitors and Immunomodulatory Drugs

Free
Stefan Knop, Hartmut Goldschmidt, MD, Marc S Raab, MD PhD, Monika Szarejko, Artur Jurczyszyn, MD, Jan Dürig, Sara Bringhen, Barbara Gamberi, MD, Angelo Vacca, Jorge Castellano Acosta, MD, Guy Lemaillet, PhD, Cedric Cortijo, PhD, Bansod Sudhir, Norbert Grząśko, MDPhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1980.
https://doi.org/10.1182/blood-2018-99-112859
Published: 2018
Journal Articles

The Prognostic Impact of t(14;20) in Multiple Myeloma - a Multicenter Retrospective Study of 26 Patients

Free
Artur Jurczyszyn, MD, Sarah Goldman-Mazur, MD, Jorge J. Castillo, MD, Anna Waszczuk-Gajda, Norbert Grząśko, MD PhD, Max Bittrich, MD, Andrew J Yee, MD, Anna Suska, MD, Deepu Madduri, MD, Saurabh Chhabra, MD, Ariel Kleman, MD, Parameswaran Hari, MBBS, MD, Stuart L. Goldberg, MD, Aimee Chappell, Massimo Gentile, David H. Vesole, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5600.
https://doi.org/10.1182/blood-2018-99-115816
Published: 2018
Journal Articles

Comparison of Myeloma Cells Killing Efficiency by Geldanamycin and Its Analogs.

Free
Anna Zebzda, MSci, Artur Jurczyszyn, MD,PhD, Wojciech Czogala, MD, Ewa Lesko, MSci, Jolanta Gozdzik, MD,PhD, Aleksander B. Skotnicki, MD,PhD, Marcin Majka, PhD
Journal: Blood
Blood (2006) 108 (11): 5027.
https://doi.org/10.1182/blood.V108.11.5027.5027
Published: 2006
Journal Articles

C-met Receptor as a Potential Target for the Treatment of Patients with Multiple Myeloma.

Free
Marcin Majka, PhD, Artur Jurczyszyn, MD, PhD, Anna Zebzda, MSci, Wojciech Czogala, MD, Ewa Lesko, MSci, Zbigniew Rudzki, MD, PhD, Jolanta Gozdzik, MD, PhD, Teresa Wolska-Smolen, MD, PhD, Aleksander B. Skotnicki, MD, PhD, Mariusz Z. Ratajczak, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 3395.
https://doi.org/10.1182/blood.V106.11.3395.3395
Published: 2005